The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
The Clinical Features of Sarcoidosis: A Comprehensive Review
Abstract
Sarcoidosis has innumerable clinical manifestations, as the disease may affect every body organ. Furthermore, the severity of sarcoidosis involvement may range from an asymptomatic state to a life-threatening condition. This manuscript reviews a wide variety of common and less common clinical characteristics of sarcoidosis. These manifestations are presented organ by organ, although additional sections describe systemic and multiorgan presentations of sarcoidosis. The lung is the organ most commonly involved with sarcoidosis with at least 90 % of sarcoidosis patients demonstrating lung involvement in most series. The skin, eye, liver, and peripheral lymph node are the next most commonly clinically involved organs in most series, with the frequency of involvement ranging from 10 to 30 %. The actual frequency of sarcoidosis organ involvement is probably much higher as it is frequently asymptomatic and may avoid detection. This is particularly common with lung, liver, cardiac, and bone involvement. Cardiac sarcoidosis is present in 25 % of all sarcoidosis but only causes clinical problems in 5 % of them. Nevertheless, unlike sarcoidosis involvement of most other organs, it may be suddenly fatal. Therefore, it is important to screen for cardiac sarcoidosis in all sarcoidosis patients. All sarcoidosis patients should also be screened for eye involvement as asymptomatic patients may have eye involvement that may cause permanent vision impairment. Pulmonary fibrosis from sarcoidosis is usually slowly progressive but may be life-threatening because of the development of respiratory failure, pulmonary hypertension, or hemoptysis related to a mycetoma or bronchiectasis. Some manifestations of sarcoidosis are not organ-specific and probably are the result of a release of mediators from the sarcoid granuloma. Two such manifestations include small fiber neuropathy and fatigue syndromes, and they are observed in a large percentage of patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary treatment for sarcoidosis is systemic steroids, chloroquine, immunosuppressants, and lung-transplantation.237,238,256,257”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [256]
In the citing paper
“Submucosal yellow nodules representative of intramucosal granulomas may be identified in mucosal biopsies, while nasal polyps, rhinophyma, and septal perforations have also been reported.238,256”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [256]
Citations
Cites
Fitzpatrick’s Dermatology in General Medicine
(1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70018-x · Cited by 3,233
Smith-Bindman, R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.427 · Cited by 2,464 · cited 1×
“Because the radiation risk of HRCT is significant [39], serial HRCT to monitor sarcoidosis are potentially dangerous and are probably of less value that following symptoms and pulmonary function [40].”
BackgroundClinical Characteristics of Patients in a Case Control Study of Sarcoidosis
BAUGHMAN, R. P., TEIRSTEIN, A. S., JUDSON, M. A., ROSSMAN, M. D., YEAGER, H., BRESNITZ, E. A., DePALO, L., HUNNINGHAKE, G., IANNUZZI, M. C., JOHNS, C. J., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104046 · Cited by 1,808 · cited 2×
“Table 3 shows the relative frequencies of sarcoidosis organ involvement in several large cohorts [12, 68, 206].”
BackgroundSelf-citationImages in Cardiovascular Medicine
(2012) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2012.05.013 · Cited by 1,519
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479 · cited 2×
“Recently, several authors have advocated eliciting cardiac symptoms, ECG, and echocardiography for screening [101, 102], although data supporting this approach are currently lacking.”
BackgroundSelf-citationHunninghake, G. W., Costabel, U., Ando, M., Baughman, R. P., Cordier, J. F., du Bois, R. M., Eklúnd, A., Kitaichi, M., Lynch, J. P., Rizzato, G., et al. (1999) · PubMed · Cited by 1,324
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.
Silverman, K. J., Hutchins, G. M., & Bulkley, B. H. (1978) · Circulation · doi:10.1161/01.cir.58.6.1204 · Cited by 984 · cited 1×
“Symptomatic cardiac sarcoidosis develops in approximately 5 % of patients [99], although up to 25 % of individuals with sarcoidosis have evidence of cardiac sarcoidosis at autopsy [100].”
BackgroundA Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors
Newman, L. S., Rose, C. S., Bresnitz, E. A., Rossman, M. D., Barnard, J., Frederick, M., Terrin, M. L., Weinberger, S. E., Moller, D. R., McLennan, G., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-249oc · Cited by 801
Self-citationRoberts, W. C., McAllister, H. A., & Ferrans, V. J. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90121-8 · Cited by 789 · cited 3×
“Ventricular arrhythmias are caused by direct granulomatous inflammation of the myocardium [105].”
BackgroundCentral nervous system sarcoidosisdiagnosis and management
Zajicek, J. P. (1999) · QJM · doi:10.1093/qjmed/92.2.103 · Cited by 742 · cited 1×
“Cranial nerve involvement is the most common manifestation of neurosarcoidosis [137–139, 143, 144].”
BackgroundSarcoidosis and Its Neurological Manifestations
Stern, B. J., Krumholz, A., Johns, C., Scott, P., & Nissim, J. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060080095022 · Cited by 714 · cited 3×
“The facial nerve is the most frequent cranial nerve affected [138, 140], and the resulting facial nerve palsy may be unilateral or bilateral [138, 145].”
BackgroundOst, D., Fein, A. M., & Feinsilver, S. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp012290 · Cited by 680
Yazaki, Y., Isobe, M., Hiroe, M., Morimoto, S.-I., Hiramitsu, S., Nakano, T., Izumi, T., & Sekiguchi, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01978-6 · Cited by 664 · cited 1×
“Congestive heart failure is a common manifestation of cardiac sarcoidosis [103, 109].”
BackgroundPrognosis of Intrathoracic Sarcoidosis in England
Scadding, J. G. (1961) · BMJ · doi:10.1136/bmj.2.5261.1165 · Cited by 638 · cited 1×
“A chest radiographic “staging system” was developed for sarcoidosis several decades ago (Table 1) [28].”
BackgroundSmedema, J.-P., Snoep, G., van Kroonenburgh, M. P. G., van Geuns, R.-J., Dassen, W. R. M., Gorgels, A. P. M., & Crijns, H. J. G. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.047 · Cited by 566
Neurologic Manifestations in Sarcoidosis: Review of the Literature, with a Report of 23 Cases
DELANEY, P. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-3-336 · Cited by 560 · cited 2×
“Symptomatic neurosarcoidosis is seen in 5 to 13 % of sarcoidosis patients [138–141].”
BackgroundMetabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.
Adams, J. S., Sharma, O. P., Gacad, M. A., & Singer, F. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111147 · Cited by 545
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
Judson, M. A., Costabel, U., Drent, M., Wells, A. U., Maier, L. A., Koth, L. L., Shigemitsu, H., Culver, D. A., Gelfand, J. M., Valeyre, D., et al. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 502
Self-citationMeasuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS)
de Vries, J., Michielsen, H., Van Heck, G. L., & Drent, M. (2004) · British Journal of Health Psychology · doi:10.1348/1359107041557048 · Cited by 424 · cited 1×
“PRO that is disease-specific for sarcoidosis where an important difference has been established [218].”
BackgroundSarcoidosis-related Mortality in the United States from 1988 to 2007
Swigris, J. J., Olson, A. L., Huie, T. J., Fernandez-Perez, E. R., Solomon, J., Sprunger, D., & Brown, K. K. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1679oc · Cited by 400 · cited 2×
“However, it appears that the death rate from sarcoidosis is rising [5].”
BackgroundCardiac Involvement in Patients with Sarcoidosis
Mehta, D., Lubitz, S. A., Frankel, Z., Wisnivesky, J. P., Einstein, A. J., Goldman, M., Machac, J., & Teirstein, A. (2008) · Chest · doi:10.1378/chest.07-2784 · Cited by 398 · cited 2×
“Although each of these three screening tests was less than 60 % sensitive in isolation, there was 100 % sensitivity for at least one of these tests being abnormal [133].”
BackgroundOcular Involvement in Chronic Sarcoidosis
Jabs, D. A., & Johns, C. J. (1986) · American Journal of Ophthalmology · doi:10.1016/0002-9394(86)90001-2 · Cited by 391 · cited 2×
“Lacrimal gland involvement in sarcoidosis occurs in up to one-quarter of cases and may present as lacrimal gland enlargement and/or a dry eyes (“sicca”) syndrome [77, 78].”
BackgroundIshimaru, S., Tsujino, I., Takei, T., Tsukamoto, E., Sakaue, S., Kamigaki, M., Ito, N., Ohira, H., Ikeda, D., Tamaki, N., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi180 · Cited by 387 · cited 6×
“The specificity of PETmay be enhanced by performing a myocardial perfusion scan to differentiate PET-positive uptake from sarcoidosis to that from a perfusion defect [135, 136].”
MethodInfluentialNeurosarcoidosis: a clinical dilemma
Hoitsma, E., Faber, C. G., Drent, M., & Sharma, O. P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00805-1 · Cited by 382 · cited 2×
“Approximately 15 % of neurosarcoidosis patients develop a peripheral neuropathy [152, 154].”
BackgroundReversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis
TELLIER, P., PAYCHA, F., ANTONY, I., NITENBERG, A., VALEYRE, D., FOULT, J., & BATTESTI, J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90536-0 · Cited by 370 · cited 1×
“Therefore, surrogate tests have been suggested for diagnosis including thallium 201 scintigraphy [122, 123], technetium 99 scintigraphy [124], gallium 67 scintigraphy [125], reversal of scintigraphy defects with exercise or dipyridimole (“reverse distribution”) [123], PET [126, 127], and magnetic resonance imaging (MR…”
MethodJudson, M. A., Boan, A. D., & Lackland, D. T. (2012) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 351
Self-citationOcular involvement in sarcoidosis
ROTHOVA, A. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.1.110 · Cited by 341
Diagnosis and Management of Neurological Sarcoidosis
Lower, E. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.16.1864 · Cited by 330 · cited 1×
“The facial nerve is the most frequent cranial nerve affected [138, 140], and the resulting facial nerve palsy may be unilateral or bilateral [138, 145].”
BackgroundOhira, H., Tsujino, I., Ishimaru, S., Oyama, N., Takei, T., Tsukamoto, E., Miura, M., Sakaue, S., Tamaki, N., & Nishimura, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0650-8 · Cited by 329
Teirstein, A. S., Machac, J., Almeida, O., Lu, P., Padilla, M. L., & Iannuzzi, M. C. (2007) · Chest · doi:10.1378/chest.07-1178 · Cited by 329 · cited 1×
“PET scanning is particularly useful in identifying sarcoidosis occult involvement of peripheral lymph nodes [182].”
BackgroundPrognostic Factors Predicting the Outcome of Sarcoidosis: An Analysis of 818 Patients
(1983) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067778 · Cited by 328 · cited 1×
“Lupus pernio is associated with severe pulmonary disease and a poor prognosis from sarcoidosis [90, 91].”
BackgroundKim, J. S., Judson, M. A., Donnino, R., Gold, M., Cooper, L. T., Prystowsky, E. N., & Prystowsky, S. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.09.009 · Cited by 328
Self-citationAdams, J. S., & Gacad, M. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.4.755 · Cited by 323
Treatment of Sarcoidosis With Infliximab
Doty, J. D., Mazur, J. E., & Judson, M. A. (2005) · Chest · doi:10.1378/chest.127.3.1064 · Cited by 312 · cited 1×
“However, bone involvement of the digits and vertebral bodies may cause significant pain and warrant therapy [195–197].”
BackgroundSelf-citationBell, N. H., Stern, P. H., Pantzer, E., Sinha, T. K., & Deluca, H. F. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109442 · Cited by 301
Sarcoidosis with Pulmonary Fibrosis: CT Patterns and Correlation with Pulmonary Function
Abehsera, M., Valeyre, D., Grenier, P., Jaillet, H., Battesti, J. P., & Brauner, M. W. (2000) · American Journal of Roentgenology · doi:10.2214/ajr.174.6.1741751 · Cited by 293 · cited 1×
“Obstruction is actually quite common with stage 4 fibrocystic disease [36] as the fibrosis-induced lung distortion may narrow airways [16, 23, 36].”
BackgroundHepatic Sarcoidosis: Clinicopathologic Features in 100 Patients
Devaney, K., Goodman, Z. D., Epstein, M. S., Zimmerman, H. J., & Ishak, K. G. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199312000-00009 · Cited by 287 · cited 1×
“The most common symptoms associated with hepatic sarcoidosis are abdominal pain and pruritus [169].”
BackgroundJudson, M. A., Baughman, R. P., Teirstein, A. S., Ml, T., & Yeager, H. (1999) · PubMed · Cited by 284
Self-citationLöfgren’s syndrome revisited: a study of 186 patients
Mañá, J., Gómez-Vaquero, C., Montero, A., Salazar, A., Marcoval, J., Valverde, J., Manresa, F., & Pujol, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00223-5 · Cited by 272 · cited 1×
“The syndrome tends to have a good prognosis [84, 85], although not always.”
BackgroundStage IV sarcoidosis: comparison of survival with the general population and causes of death
Nardi, A., Brillet, P.-Y., Letoumelin, P., Girard, F., Brauner, M., Uzunhan, Y., Naccache, J.-M., Valeyre, D., & Nunes, H. (2011) · European Respiratory Journal · doi:10.1183/09031936.00187410 · Cited by 272 · cited 2×
“Patients with stage 4 chest radiographs tend to have the most severe pulmonary function impairment [44], and they are the patients most likely to have progressive pulmonary disease [45, 46].”
BackgroundIncidence of Pulmonary Hypertension and Its Clinical Relevance in Patients With Sarcoidosis
Handa, T., Nagai, S., Miki, S., Fushimi, Y., Ohta, K., Mishima, M., & Izumi, T. (2006) · Chest · doi:10.1378/chest.129.5.1246 · Cited by 270 · cited 1×
“The most common cause of sarcoidosis associated pulmonary hypertension is fibrocystic sarcoidosis that causes distortion and compression of the pulmonary vasculature [50].”
BackgroundRacial difference in cardiac sarcoidosis incidence observed at autopsy.
Iwai, K., Sekiguti, M., HOSODA, Y., DeRemee, R. A., Tazelaar, H. D., Sharma, O. P., Maheshwari, A., & Noguchi, T. I. (1994) · PubMed · Cited by 265
Cardiac Sarcoidosis: A Retrospective Study of 41 Cases
Chapelon-Abric, C., de Zuttere, D., Duhaut, P., Veyssier, P., Wechsler, B., Huong, D. L. T., de Gennes, C., Papo, T., Blétry, O., Godeau, P., et al. (2004) · Medicine · doi:10.1097/01.md.0000145367.17934.75 · Cited by 261 · cited 1×
“Congestive heart failure is a common manifestation of cardiac sarcoidosis [103, 109].”
BackgroundIntraepidermal nerve fiber density and its application in sarcoidosis
Bakkers, M., Merkies, I. S. J., Lauria, G., Devigili, G., Penza, P., Lombardi, R., Hermans, M. C. E., van Nes, S. I., De Baets, M., & Faber, C. G. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bacf05 · Cited by 250 · cited 1×
“Sarcoidosis may also cause a small fiber neuropathy [156, 157], although the mechanism involved probably relates to a systemic release of inflammatory mediators rather than direct granulomatous inflammation of the small fibers [158].”
BackgroundNeurosarcoidosis: a study of 30 new cases
Joseph, F. G., & Scolding, N. J. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.151977 · Cited by 248 · cited 1×
“Cranial nerve involvement is the most common manifestation of neurosarcoidosis [137–139, 143, 144].”
BackgroundClinical Significance of Myocardial Magnetic Resonance Abnormalities in Patients with Sarcoidosis
Vignaux, O., Dhote, R., Duboc, D., Blanche, P., Dusser, D., Weber, S., & Legmann, P. (2002) · Chest · doi:10.1378/chest.122.6.1895 · Cited by 238 · cited 1×
“Therefore, surrogate tests have been suggested for diagnosis including thallium 201 scintigraphy [122, 123], technetium 99 scintigraphy [124], gallium 67 scintigraphy [125], reversal of scintigraphy defects with exercise or dipyridimole (“reverse distribution”) [123], PET [126, 127], and magnetic resonance imaging (MR…”
MethodSarcoidosis: A comprehensive review and update for the dermatologist
Haimovic, A., Sanchez, M., Judson, M. A., & Prystowsky, S. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.11.965 · Cited by 237 · cited 2×
“Although the most common sarcoidosis skin lesion is a firm 2 to 5 mm in diameter papule that is often translucent red-brown or yellow-brown in color [87], these lesions may had quite a varied appearance and may mimic many other skin diseases [88].”
BackgroundSelf-citationLynch, J. P., Kazerooni, E. A., & Gay, S. E. (1997) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70417-2 · Cited by 235
Löfgren's Syndrome: Human Leukocyte Antigen Strongly Influences the Disease Course
Grunewald, J., & Eklund, A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1082oc · Cited by 234 · cited 1×
“A recent study of Lofgren’s syndrome patients showed that the presence of the HLA DRB1*03-positive allele was associated with a 95 % chance of resolution of sarcoidosis at 2 years, whereas the odds were only 50 % is this allele was absent [86].”
BackgroundSurvival in Sarcoidosis-Associated Pulmonary Hypertension
Baughman, R. P., Engel, P. J., Taylor, L., & Lower, E. E. (2010) · Chest · doi:10.1378/chest.09-2002 · Cited by 234 · cited 2×
“The diffusing capacity may be a useful screening test to detect sarcoidosis associated pulmonary hypertension (vide infra) [48].”
BackgroundTavora, F., Cresswell, N., Li, L., Ripple, M., Solomon, C., & Burke, A. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.03.068 · Cited by 230 · cited 2×
“Sudden death may occur from either heart block or an uncontrolled ventricular arrhythmia [8, 102].”
BackgroundThe CT findings of pulmonary sarcoidosis: analysis of 25 patients
Muller, N., Kullnig, P., & Miller, R. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.6.1179 · Cited by 225 · cited 1×
“The granulomatous lesions of pulmonary sarcoidosis have a predilection for the perilymphatic areas [19–21] and bronchovascular bundles [22].”
BackgroundPulmonary sarcoidosis: evaluation with high-resolution CT.
Brauner, M. W., Grenier, P., Mompoint, D., Lenoir, S., & de Crémoux, H. (1989) · Radiology · doi:10.1148/radiology.172.2.2748828 · Cited by 225 · cited 1×
“4) [32, 35, 36].”
Renal Sarcoidosis: Clinical, Laboratory, and Histologic Presentation and Outcome in 47 Patients
Mahévas, M., Lescure, F. X., Boffa, J.-J., Delastour, V., Belenfant, X., Chapelon, C., Cordonnier, C., Makdassi, R., Piette, J.-C., Naccache, J.-M., et al. (2009) · Medicine · doi:10.1097/md.0b013e31819de50f · Cited by 224 · cited 1×
“Sarcoidosis rarely involves the thyroid (that may cause hyper- or hypothyroidism), renal parenchyma [200], muscles [142], tendon sheaths [201], prostate [202], breast [203], and male and female reproductive tracts [202, 204, 205].”
BackgroundSmall fibre neuropathy in sarcoidosis
Hoitsma, E., Marziniak, M., Faber, C., Reulen, J., Sommer, C., De Baets, M., & Drent, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08912-2 · Cited by 220 · cited 1×
“Sarcoidosis small fiber neuropathy may also manifest as an autonomic neuropathy causing changes in sweating patterns (hyper- and hypohidrosis), palpitations, orthostatic hypotension, gastrointestinal problems (nausea, constipation, diarrhea), flushing, sexual dysfunction, and bowel bladder disturbances [158–160].”
BackgroundPredicting Mortality in Patients With Sarcoidosis Awaiting Lung Transplantation
Shorr, A. F., Davies, D. B., & Nathan, S. D. (2003) · Chest · doi:10.1016/s0012-3692(15)37649-2 · Cited by 217 · cited 1×
“Pulmonary hypertension is a life-threatening complication of sarcoidosis [7, 48, 49].”
BackgroundSharma, O. P., Maheshwari, A., & Thaker, K. (1993) · Chest · doi:10.1378/chest.103.1.253 · Cited by 217
Steele, J. D. (1963) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33683-9 · Cited by 213
Shimada, T., Shimada, K., Sakane, T., Ochiai, K., Tsukihashi, H., Fukui, M., Inoue, S.-I., Katoh, H., Murakami, Y., Ishibashi, Y., et al. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00677-5 · Cited by 213 · cited 1×
“Therefore, surrogate tests have been suggested for diagnosis including thallium 201 scintigraphy [122, 123], technetium 99 scintigraphy [124], gallium 67 scintigraphy [125], reversal of scintigraphy defects with exercise or dipyridimole (“reverse distribution”) [123], PET [126, 127], and magnetic resonance imaging (MR…”
MethodTwo year prognosis of sarcoidosis: the ACCESS experience.
Judson, M. A., Baughman, R. P., Thompson, B. W., Teirstein, A. S., Ml, T., Rossman, Yeager, H., McLennan, G., Bresnitz, E. A., DePalo, L., et al. (2003) · PubMed · Cited by 211
Self-citationSharma, O. P. (1997) · Chest · doi:10.1378/chest.112.1.220 · Cited by 204 · cited 1×
“Sarcoidosis can affect any portion of the nervous system [137].”
BackgroundAhmadian, A., Brogan, A., Berman, J., Sverdlov, A. L., Mercier, G., Mazzini, M., Govender, P., Ruberg, F. L., & Miller, E. J. (2014) · Journal of Nuclear Cardiology · doi:10.1007/s12350-014-9901-9 · Cited by 198 · cited 1×
“The specificity of PETmay be enhanced by performing a myocardial perfusion scan to differentiate PET-positive uptake from sarcoidosis to that from a perfusion defect [135, 136].”
BackgroundCutaneous involvement in sarcoidosis: analysis of the features in 170 patients
Yanardağ, H., Pamuk, Ö. N., & Karayel, T. (2003) · Respiratory Medicine · doi:10.1016/s0954-6111(03)00127-6 · Cited by 198 · cited 1×
“Lupus pernio is associated with severe pulmonary disease and a poor prognosis from sarcoidosis [90, 91].”
BackgroundArdehali, H., Howard, D. L., Hariri, A., Qasim, A., Hare, J. M., Baughman, K. L., & Kasper, E. K. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.10.006 · Cited by 195 · cited 1×
“Although endomyocardial biopsy is highly specific for the diagnosis of cardiac sarcoidosis [120], it is invasive and has a very low yield as the disease is usually patchy [121].”
BackgroundWinters, S. L., Cohen, M., Greenberg, S., Stein, B., Curwin, J., Pe, E., & Gomes, J. A. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90750-4 · Cited by 194
Cardiac Sarcoidosis: Spectrum of MRI Features
Vignaux, O. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.1.01840249 · Cited by 192 · cited 1×
“Therefore, surrogate tests have been suggested for diagnosis including thallium 201 scintigraphy [122, 123], technetium 99 scintigraphy [124], gallium 67 scintigraphy [125], reversal of scintigraphy defects with exercise or dipyridimole (“reverse distribution”) [123], PET [126, 127], and magnetic resonance imaging (MR…”
MethodShammas, R. L., & Movahed, A. (1993) · Clinical Cardiology · doi:10.1002/clc.4960160603 · Cited by 190
Sarcoidosis: The Nephrologist’s Perspective
Berliner, A. R., Haas, M., & Choi, M. J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.07.022 · Cited by 181 · cited 1×
“Sarcoidosis patients may develop hypercalcemia or hypercalciuria [183, 184], with the latter being three times more common [184–186].”
BackgroundJudson, M. A. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.009 · Cited by 177 · cited 1×
“Similar to Lofgren’s syndrome, this constellation of findings is so specific for sarcoidosis that the diagnosis can be made on clinical grounds without the need for a confirmatory biopsy [233].”
BackgroundSelf-citationCharacteristics and Outcomes of Patients With Sarcoidosis Listed for Lung Transplantation
Arcasoy, S. M., Christie, J. D., Pochettino, A., Rosengard, B. R., Blumenthal, N. P., Bavaria, J. E., & Kotloff, R. M. (2001) · Chest · doi:10.1378/chest.120.3.873 · Cited by 169 · cited 2×
“The majority of deaths are the result of pulmonary sarcoidosis where pulmonary fibrosis and/or pulmonary hypertension has developed [6, 7].”
BackgroundNecrotizing Sarcoid Granulomatosis
Churg, A., Carrington, C. B., & Gupta, R. (1979) · Chest · doi:10.1378/chest.76.4.406 · Cited by 168
Development of Sarcoidosis in Cosmetic Tattoos
Antonovich, D. D., & Callen, J. P. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.7.869 · Cited by 167 · cited 1×
“8), scars, skin piercings, and other sites of trauma [92, 93].”
BackgroundPhenotyping Sarcoidosis from a Pulmonary Perspective
Prasse, A., Katic, C., Germann, M., Buchwald, A., Zissel, G., & Müller-Quernheim, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-742oc · Cited by 166 · cited 2×
“Alternatively, sarcoidosis may present as a subacute disease with an insidious onset [1].”
BackgroundTadamura, E., Yamamuro, M., Kubo, S., Kanao, S., Saga, T., Harada, M., Ohba, M., Hosokawa, R., Kimura, T., Kita, T., et al. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.185.1.01850110 · Cited by 165 · cited 1×
“Although endomyocardial biopsy is highly specific for the diagnosis of cardiac sarcoidosis [120], it is invasive and has a very low yield as the disease is usually patchy [121].”
BackgroundOrbital and Adnexal Sarcoidosis
Prabhakaran, V. C. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.12.1657 · Cited by 164 · cited 1×
“Other eye manifestations of sarcoidosis include involvement of the adnexa and the orbit [80], scleritis [77], extraocular muscles [81], and skin involvement adjacent to the eye.”
BackgroundPrognosticators for Visual Outcome in Sarcoid Uveitis
Dana, M.-R., Merayo-Lloves, J., Schaumberg, D. A., & Foster, C. S. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30417-x · Cited by 160 · cited 1×
“If the inflammatory changes are identified and effectively treated, permanent vision impairment and vision loss can be averted [69, 70].”
BackgroundEndobronchial Biopsy for Sarcoidosis
Shorr, A. F., Torrington, K. G., & Hnatiuk, O. W. (2001) · Chest · doi:10.1378/chest.120.1.109 · Cited by 159 · cited 2×
“The high frequency of wheezing and cough in pulmonary sarcoidosis may be attributable to the fact that the disease has a predilection for the airways [17].”
BackgroundOkayama, K., Kurata, C., Tawarahara, K., Wakabayashi, Y., Chida, K., & Sato, A. (1995) · Chest · doi:10.1378/chest.107.2.330 · Cited by 159 · cited 1×
“Therefore, surrogate tests have been suggested for diagnosis including thallium 201 scintigraphy [122, 123], technetium 99 scintigraphy [124], gallium 67 scintigraphy [125], reversal of scintigraphy defects with exercise or dipyridimole (“reverse distribution”) [123], PET [126, 127], and magnetic resonance imaging (MR…”
MethodSmedema, J., Snoep, G., van Kroonenburgh, M. J. P. G., van Geuns, R., Dassen, W. R. M., Gorgels, A. P. M., & Crijns, H. J. G. M. (2005) · CHEST Journal · doi:10.1378/chest.128.1.30 · Cited by 156 · cited 1×
“Conduction disturbances can occur in practically any location and can lead to left or right bundle branch block that can be incomplete or complete, atrioventicular block of any degree, and even sinus node arrest [102–105].”
BackgroundLarge Coalescent Parenchymal Nodules in Pulmonary Sarcoidosis: “Sarcoid Galaxy” Sign
Nakatsu, M., Hatabu, H., Morikawa, K., Uematsu, H., Ohno, Y., Nishimura, K., Nagai, S., Izumi, T., Konishi, J., & Itoh, H. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.178.6.1781389 · Cited by 154
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.
Baughman, R. P., Nagai, S., Balter, M. S., Costabel, U., Drent, M., du Bois, R. M., Grutters, J. C., Judson, M. A., Lambiri, I., Lower, E. E., et al. (2011) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 152
Self-citationAirway Involvement in Sarcoidosis
Polychronopoulos, V. S., & Prakash, U. B. S. (2009) · CHEST Journal · doi:10.1378/chest.08-2569 · Cited by 151
Chang, B. W., Steimel, J., Möller, D. R., Baughman, R. P., Judson, M. A., Yeager, H., Teirstein, A. S., Rossman, M. D., & Rand, C. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2004177 · Cited by 145 · cited 1×
“Fatigue may not be directly related to sarcoidosis but, rather, be associated with corticosteroid use, obstructive sleep apnea, depression, and stress that are common problems in sarcoidosis patients [213–215].”
BackgroundSelf-citationAbdominal CT findings in sarcoidosis: radiologic and clinical correlation.
Warshauer, D. M., Dumbleton, S. A., Molina, P. L., Yankaskas, B. C., Parker, L. A., & Woosley, J. T. (1994) · Radiology · doi:10.1148/radiology.192.1.8208972 · Cited by 143 · cited 2×
“Such combinations include liver and spleen sarcoidosis [172], lupus pernio and nasal sinus involvement (possibly by direct extension) [234, 235], and eye and neurosarcoidosis [235].”
BackgroundEvans, M., Sharma, O. P., LABREE, L. D., Smith, R. E., & Rao, N. A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.074 · Cited by 142 · cited 1×
“Uveitis is the most common manifestation of eye sarcoidosis [71].”
BackgroundWhat happens to patients with pulmonary aspergilloma? Analysis of 23 cases.
Rafferty, P., Biggs, B., Crompton, G. K., & Grant, I. W. (1983) · Thorax · doi:10.1136/thx.38.8.579 · Cited by 141 · cited 1×
“threatening hemoptysis occurs in more than one-half of individuals with pulmonary aspergillomas [54], and concomitant sarcoidosis is a risk factor for death [55].”
BackgroundCourse and prognosis of sarcoidosis
Sones, M., & Israel, H. L. (1960) · The American Journal of Medicine · doi:10.1016/0002-9343(60)90009-7 · Cited by 140 · cited 2×
“Parenchymal lung opacities are present in 25 to 60 % [27].”
BackgroundNodular sarcoidosis of the liver and spleen: analysis of 32 cases.
Warshauer, D. M., Molina, P. L., Hamman, S. M., Koehler, R., Paulson, E. K., Bechtold, R. E., Perlmutter, M. L., Hiken, J. N., Francis, I. R., & Cooper, C. J. (1995) · Radiology · doi:10.1148/radiology.195.3.7754007 · Cited by 132 · cited 2×
“10) that are much more frequently detected than hepatic nodules and usually do not require intravenous contrast to identify [172–175].”
BackgroundNeurosarcoidosis: Clinical manifestations, diagnosis and treatment
Nozaki, K., & Judson, M. A. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2011.12.017 · Cited by 124 · cited 2×
“Neurosarcoidosis is often classified as affecting one or more of the following portions of the nervous system: the cranial nerves, brain, leptomeninges, and peripheral nerves [142].”
BackgroundSelf-citationCutaneous sarcoidosis: Definitions and types of lesions
Elgart, M. L. (1986) · Clinics in Dermatology · doi:10.1016/0738-081x(86)90032-5 · Cited by 122 · cited 1×
“Other appearances of specific sarcoidosis lesions include annular lesions [94], plaques [95], psoriaform lesions [88], intradermal nodules “Derrier-Roussy lesions” [96], and ulcers [97, 98].”
BackgroundSupraventricular Arrhythmias in Patients With Cardiac Sarcoidosis
Viles-González, J. F., Pastori, L. J., Fischer, A., Wisnivesky, J. P., Goldman, M., & Mehta, D. (2013) · CHEST Journal · doi:10.1378/chest.11-3214 · Cited by 122 · cited 1×
“Atrial arrhythmias may occur with sarcoidosis, although they are often related to atrial dilatation from left ventricular dysfunction or cor pulmonale rather than direct granulomatous inflammation of the atria [105, 108].”
BackgroundBergin, C. J., Bell, D. Y., Coblentz, C. L., Chiles, C., Gamsu, G., MacIntyre, N. R., Coleman, R. E., & Putman, C. E. (1989) · Radiology · doi:10.1148/radiology.171.3.2717731 · Cited by 121 · cited 1×
“Patients with stage 4 chest radiographs tend to have the most severe pulmonary function impairment [44], and they are the patients most likely to have progressive pulmonary disease [45, 46].”
BackgroundPathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern
Iwai, K., Takemura, T., Kitaici, M., Kawabata, Y., & Matsui, Y. (1993) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1993.tb01149.x · Cited by 121 · cited 1×
“Granulomatous myocardial involvement may occasionally lead to the development of ventricular aneurysms or thinning of the ventricular free wall that may rarely rupture [111].”
BackgroundSeverity of pulmonary involvement and 18F-FDG PET activity in sarcoidosis
Mostard, R. L. M., Verschakelen, J., van Kroonenburgh, M. J. P. G., Nelemans, P. J., Wijnen, P. A. H. M., Vöö, S. A., & Drent, M. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.11.011 · Cited by 121 · cited 1×
“A recent study demonstrated that 85 % of such patients have significant lung uptake on positron emission tomography (PET), suggesting that they have active disease [37].”
BackgroundIdiopathic giant cell myocarditis and cardiac sarcoidosis
Blauwet, L. A., & Cooper, L. T. (2013) · Heart Failure Reviews · doi:10.1007/s10741-012-9358-3 · Cited by 119 · cited 1×
“Congestive heart failure usually is the result of granulomatous infiltration of the myocardium that may cause systolic of diastolic dysfunction [102, 110].”
BackgroundPleural Effusions in a Series of 181 Outpatients With Sarcoidosis
Huggins, J. T., Doelken, P., Sahn, S. A., King, L., & Judson, M. A. (2006) · CHEST Journal · doi:10.1378/chest.129.6.1599 · Cited by 119 · cited 4×
“Pleural effusions are rare in sarcoidosis with a prevalence of less than 3 % in one outpatient series [57].”
BackgroundInfluentialSelf-citationIncreased Risk of Pulmonary Embolism Among US Decedents With Sarcoidosis From 1988 to 2007
Swigris, J. J., Olson, A. L., Huie, T. J., Pérez, E. R. F., Solomon, J. J., Sprunger, D. B., & Brown, K. K. (2011) · CHEST Journal · doi:10.1378/chest.11-0324 · Cited by 117 · cited 1×
“However, there are several other causes of pulmonary hypertension in sarcoidosis including a granulomatous pulmonary vasculopathy [51], pulmonary venous hypertension that is much more commonly the result of an ischemic cardiomyopathy rather than from cardiac involvement with sarcoidosis, parenchymal sarcoidosis-induce…”
BackgroundEPIDEMIOLOGY OF SARCOIDOSIS IN THE U. S. NAVY1
Sartwell, P. E., & Edwards, L. B. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121609 · Cited by 112 · cited 2×
“As the above would imply, asymptomatic pulmonary sarcoidosis is more common in whites than blacks [11].”
BackgroundAizer, A., Stern, E. H., Gomes, J. A., Teirstein, A. S., Eckart, R. E., & Mehta, D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.059 · Cited by 112 · cited 1×
“Ventricular tachycardia may be sustained or nonsustained and, occasionally, cannot be controlled with medical therapy [106, 107].”
BackgroundCasella, F., & Allon, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v391555 · Cited by 112
Fatigue in sarcoidosis: a systematic review
de Kleijn, W. P. E., Vries, J. D., Lower, E. E., Elfferich, M., Baughman, R. P., & Drent, M. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832d0403 · Cited by 112 · cited 1×
“Fatigue is reported by more than 50 % of sarcoidosis patients [209–212].”
BackgroundThe Use of 201Thallium for Myocardial Perfusion Imaging in Sarcoid Heart Disease
Bulkley, B. H., Rouleau, J. R., Whitaker, J. Q., Strausś, H. W., & Pitt, B. (1977) · CHEST Journal · doi:10.1378/chest.72.1.27 · Cited by 111 · cited 1×
“Therefore, surrogate tests have been suggested for diagnosis including thallium 201 scintigraphy [122, 123], technetium 99 scintigraphy [124], gallium 67 scintigraphy [125], reversal of scintigraphy defects with exercise or dipyridimole (“reverse distribution”) [123], PET [126, 127], and magnetic resonance imaging (MR…”
MethodLynch, J. P., Ma, Y., Koss, M., & White, E. S. (2007) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2007-970333 · Cited by 110
McKinzie, B. P., Bullington, W., Mazur, J. E., & Judson, M. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181b97635 · Cited by 109 · cited 3×
“Chest pain may occur with pulmonary sarcoidosis [15].”
BackgroundSelf-citationEfficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis
Parambil, J. G., Tavee, J. O., Zhou, L., Pearson, K. S., & Culver, D. A. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.09.015 · Cited by 109 · cited 1×
“Sarcoidosis small fiber neuropathy may also manifest as an autonomic neuropathy causing changes in sweating patterns (hyper- and hypohidrosis), palpitations, orthostatic hypotension, gastrointestinal problems (nausea, constipation, diarrhea), flushing, sexual dysfunction, and bowel bladder disturbances [158–160].”
BackgroundAssociation of fatigue with an acute phase response in sarcoidosis
Drent, M., Wirnsberger, R. M., Vries, J. D., van Dieijen‐Visser, M. P., Wouters, E. F. �., & Schols, A. M. W. J. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13d03.x · Cited by 109 · cited 1×
“It has been hypothesized that sarcoidosis-induced fatigue may be related to mediators released from granulomas [216], although a subsequent study failed to confirm this postulation [217].”
ResultLower, E. E., Harman, S., & Baughman, R. P. (2008) · CHEST Journal · doi:10.1378/chest.07-2952 · Cited by 109 · cited 1×
“Other PRO that have been used to measure fatigue in sarcoidosis include the Functional Assessment of Chronic Illness-Therapy Fatigue (FACIT-F) [220], the Fatigue Scale (FS) [211], and the Patient Reported Outcomes Measurement Information Systems (PROMIS) Fatigue Instrument (PFI) [219] that is incorporated as a domain…”
MethodMediastinoscopy in Patients With Presumptive Stage I Sarcoidosis
Reich, J. M., Brouns, M. C., O’Connor, E., & Edwards, M. J. (1998) · CHEST Journal · doi:10.1378/chest.113.1.147 · Cited by 108
Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases.
Vatti, R. R., & Sharma, O. P. (1997) · PubMed · Cited by 107
A prospective study of 32 patients with neurosarcoidosis.
Allen, R. K. A., Sellars, R. E., & Sandstrom, P. A. (2003) · PubMed · Cited by 106
Mañá, J., Salazar, A., & Manresa, F. (2009) · Respiration · doi:10.1159/000196341 · Cited by 105 · cited 1×
“Groups with higher stages tend to have more pulmonary symptoms, greater pulmonary dysfunction, lower remission rates, and higher mortality [26, 27, 29].”
BackgroundSarcoidosis in Causians, Blacks and Asians in London
Edmondstone, W. M., & Wilson, A. G. (1985) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(85)90004-x · Cited by 105 · cited 1×
“Because blacks tend to have more severe manifestations of sarcoidosis than whites [10, 12] or Asians [13], populations with different percentage of various races have different frequencies of presentations.”
BackgroundAspergilloma in Sarcoid and Tuberculosis
Tomlinson, J. R., & Sahn, S. A. (1987) · CHEST Journal · doi:10.1378/chest.92.3.505 · Cited by 105 · cited 1×
“threatening hemoptysis occurs in more than one-half of individuals with pulmonary aspergillomas [54], and concomitant sarcoidosis is a risk factor for death [55].”
BackgroundSinonasal Involvement in Sarcoidosis: A Case-Control Study of 20 Patients
Aubart, F. C., Ouayoun, M., Brauner, M., Attali, P., Kambouchner, M., Valeyre, D., & Nunès, H. (2006) · Medicine · doi:10.1097/01.md.0000236955.79966.07 · Cited by 102 · cited 3×
“SURT may present with hoarseness, sinus pain/pressure, nasal obstruction, epistaxis, nasal crusting, anosmia, or as a mass lesion [89, 179, 180].”
BackgroundOcular Manifestations of Sarcoidosis
Bradley, D., Baughman, R. P., Raymond, L. A., & Kaufman, A. H. (2002) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2002-36518 · Cited by 102
F-18 FDG PET/CT for Detecting Bone and Bone Marrow Involvement in Sarcoidosis Patients
Mostard, R. L. M., Prompers, L., Weijers, R. E., van Kroonenburgh, M. J. P. G., Wijnen, P. A. H. M., Geusens, P., & Drent, M. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182335f9b · Cited by 101 · cited 1×
“In particular, PET scans are useful in detecting bone sarcoidosis [190–192] that is often confused with metastatic malignancy [193, 194].”
BackgroundRespiratory Muscle Strength, Lung Function, and Dyspnea in Patients With Sarcoidosis
Baydur, A., Alsalek, M., Louie, S. G., & Sharma, O. P. (2001) · CHEST Journal · doi:10.1378/chest.120.1.102 · Cited by 100 · cited 1×
“Pulmonary function tests are often in the lower end of the normal range and lower in comparison with healthy control groups [42].”
BackgroundSarcoidosis: Clinical Presentation, Diagnosis, and Approach to Treatment
Judson, M. A. (2008) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31815d8276 · Cited by 98
Self-citationChronic cutaneous lesions of sarcoidosis
Marchell, R., & Judson, M. A. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.03.007 · Cited by 96 · cited 2×
“Although the most common sarcoidosis skin lesion is a firm 2 to 5 mm in diameter papule that is often translucent red-brown or yellow-brown in color [87], these lesions may had quite a varied appearance and may mimic many other skin diseases [88].”
BackgroundSelf-citationVainsencher, D. (1984) · Archives of Dermatology · doi:10.1001/archderm.1984.01650440058020 · Cited by 96
Use of Pulmonary Function Tests in the Management of Sarcoidosis
Winterbauer, R. H., & Hutchinson, J. F. (1980) · CHEST Journal · doi:10.1378/chest.78.4.640 · Cited by 91 · cited 2×
“In sarcoidosis patients with a normal lung parenchyma on chest radiograph, at least one of the following is abnormal in 20–40 %: the vital capacity, diffusing capacity, arterial PO2 at rest or exercise, or lung compliance [43].”
BackgroundBaughman, R. P., Lower, E. E., & Kaufman, A. H. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0030-1262213 · Cited by 91
Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis
Hoitsma, E., Drent, M., Verstraete, E., Faber, C. G., Troost, J., Spaans, F., & Reulen, J. P. H. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00259-1 · Cited by 90 · cited 1×
“Sarcoidosis may also cause a small fiber neuropathy [156, 157], although the mechanism involved probably relates to a systemic release of inflammatory mediators rather than direct granulomatous inflammation of the small fibers [158].”
BackgroundManagement of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Shlobin, O. A., & Nathan, S. D. (2012) · European Respiratory Journal · doi:10.1183/09031936.00175511 · Cited by 89 · cited 1×
“this fibrosis that usually determines the prognosis of the disease [2] and most of the severe complications [4].”
BackgroundGuludec, D. L., Menad, F., Faraggi, M., Weinmann, P., Battesti, J.-P., & Valeyre, D. (1994) · CHEST Journal · doi:10.1378/chest.106.6.1675 · Cited by 86
Sarcoidosis and Small-fiber Neuropathy
Tavee, J. O., & Culver, D. A. (2011) · Current Pain and Headache Reports · doi:10.1007/s11916-011-0180-8 · Cited by 81 · cited 2×
“Although these symptoms usually begin in the feet, they can spread in a patchy, noncontiguous distribution in other parts of the body [158].”
BackgroundSarcoidosis of the upper respiratory tract and its association with lupus pernio.
Neville, E., Mills, R. G., Jash, D. K., Mackinnon, D. M., Carstairs, L. S., & James, D. G. (1976) · Thorax · doi:10.1136/thx.31.6.660 · Cited by 80 · cited 1×
“Such combinations include liver and spleen sarcoidosis [172], lupus pernio and nasal sinus involvement (possibly by direct extension) [234, 235], and eye and neurosarcoidosis [235].”
BackgroundDifferential diagnosis of annular lesions.
Hsu, S., Le, E. H., & Khoshevis, M. R. (2001) · PubMed · Cited by 80
Aspergillus Lung Disease in Patients with Sarcoidosis: A Case Series and Review of the Literature
Pena, T. A., Soubani, A. O., & Samavati, L. (2011) · Lung · doi:10.1007/s00408-011-9280-9 · Cited by 79 · cited 1×
“4) [45, 53].”
Nishino, M., Lee, K. S., Itoh, H., & Hatabu, H. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.09.038 · Cited by 78 · cited 1×
“The granulomatous lesions of pulmonary sarcoidosis have a predilection for the perilymphatic areas [19–21] and bronchovascular bundles [22].”
BackgroundQuaden, C., Tillie‐Leblond, I., Delobbe, A., Delaunois, L., Verstraeten, A., Demedts, M., & Wallaert, B. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00024205 · Cited by 77 · cited 1×
“Some of these patients may have necrotizing sarcoid granulomatosis (NSG), a disease that may be a variant of sarcoidosis or a distinct entity [61].”
BackgroundThe relationship between fatigue and clinical parameters in pulmonary sarcoidosis.
Vries, J. D., Kos, S., van Dieijen‐Visser, M. P., & Drent, M. (2004) · Research portal (Tilburg University) · Cited by 77
Sarcoidosis: abdominal manifestations at CT.
BRITT, A. R., Francis, I. R., Glazer, G. M., & Ellis, J. H. (1991) · Radiology · doi:10.1148/radiology.178.1.1984330 · Cited by 76 · cited 2×
“10) that are much more frequently detected than hepatic nodules and usually do not require intravenous contrast to identify [172–175].”
BackgroundClinical Implications of Seizures in Neurosarcoidosis
Krumholz, A., Stern, B. J., & Stern, E. G. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530200084023 · Cited by 76 · cited 1×
“Other relatively rare manifestations of neurosarcoidosis include encephalopathy [138], psychosis [138, 161], hydrocephalus that may be the result of previousmeningeal involvement [161], and seizures [162].”
BackgroundAudiovestibular Manifestations of Sarcoidosis: A Review of the Literature
Colvin, I. B. (2006) · The Laryngoscope · doi:10.1097/01.mlg.0000184580.52723.9f · Cited by 76 · cited 1×
“Optic neuritis (vide supra) and sensorineural hearing loss from eighth cranial nerve involvement [146] may also occur.”
BackgroundAbdominal Manifestations of Sarcoidosis in CT Studies
Folz, S. J., Johnson, C. D., & Swensen, S. J. (1995) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199507000-00013 · Cited by 75 · cited 1×
“Hepatic nodules are found in less than 5 % of patients in most series and often require intravenous contrast to be visualized [172, 175].”
BackgroundGvozdenović, B., Mihailović-Vučinić, V., Dudvarski-Ilić, A., Žugić, V., & Judson, M. A. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.05.001 · Cited by 75 · cited 3×
“Other PRO that have been used to measure fatigue in sarcoidosis include the Functional Assessment of Chronic Illness-Therapy Fatigue (FACIT-F) [220], the Fatigue Scale (FS) [211], and the Patient Reported Outcomes Measurement Information Systems (PROMIS) Fatigue Instrument (PFI) [219] that is incorporated as a domain…”
BackgroundMethodSelf-citationLower, E. E., & Weiss, K. L. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.016 · Cited by 72
Case Report: Vascular Sarcoidosis: A Rare Cause of Pulmonary Hypertension
Smith, L. J., Lawrence, J. B., & Katzenstein, A.-L. A. (1983) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198301000-00004 · Cited by 71 · cited 1×
“However, there are several other causes of pulmonary hypertension in sarcoidosis including a granulomatous pulmonary vasculopathy [51], pulmonary venous hypertension that is much more commonly the result of an ischemic cardiomyopathy rather than from cardiac involvement with sarcoidosis, parenchymal sarcoidosis-induce…”
BackgroundAcute Pulmonary Exacerbations of Sarcoidosis
Panselinas, E., & Judson, M. A. (2012) · CHEST Journal · doi:10.1378/chest.12-1060 · Cited by 70 · cited 1×
“Because the radiation risk of HRCT is significant [39], serial HRCT to monitor sarcoidosis are potentially dangerous and are probably of less value that following symptoms and pulmonary function [40].”
BackgroundSelf-citationTreatment of Laryngeal Sarcoidosis with Intralesional Steroid Injection
Krespi, Y. P., Husain, S., Mitrani, M., & Meltzer, C. J. (1987) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348948709600622 · Cited by 68 · cited 1×
“SURT may present with hoarseness, sinus pain/pressure, nasal obstruction, epistaxis, nasal crusting, anosmia, or as a mass lesion [89, 179, 180].”
BackgroundHepatic granulomatosis and sarcoidosis: Further observations
Israel, H. L., Margolis, M. L., & Rose, L. J. (1984) · Digestive Diseases and Sciences · doi:10.1007/bf01318522 · Cited by 67
Racial and Ethnic Disparities in Sarcoidosis: From Genetics to Socioeconomics
Westney, G. E., & Judson, M. A. (2006) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.04.002 · Cited by 66 · cited 2×
“Radiographic screening studies tend to yield higher incidence rates of sarcoidosis by detecting more asymptomatic cases [10, 11].”
BackgroundSelf-citationAn Assessment of Back Pain and the Prevalence of Sacroiliitis in Sarcoidosis
Erb, N., Cushley, M. J., Kassimos, D. G., Shave, R. M., & Kitas, G. D. (2005) · CHEST Journal · doi:10.1378/chest.127.1.192 · Cited by 66 · cited 1×
“Sarcoiliitis and spondyloarthritis may be more frequent in sarcoidosis than the general population [224, 225], although it is unknown if this relates to granulomatous inflammation in these locations.”
BackgroundEndocrine aspects of neurosarcoidosis
Murialdo, G., & Tamagno, G. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345093 · Cited by 65 · cited 1×
“In addition, granulomatous infiltration of the hypothalamo-hypophysial region from sarcoidosis may cause neuroendocrine dysfunction including diabetes insidipus, adenopituitary failure, and amenorrhea– galactorrhea syndrome [163].”
BackgroundNephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study.
Rizzato, G., & Colombo, P. (1996) · PubMed · Cited by 65
Isolated Neurosarcoidosis: Case Series in 2 Sarcoidosis Centers
Nozaki, K., Scott, T. F. M., Sohn, M., & Judson, M. A. (2012) · The Neurologist · doi:10.1097/nrl.0b013e3182704d04 · Cited by 64 · cited 2×
“About 20 to 40 % have hypoglycorrhachia [153].”
BackgroundSelf-citationComputed Tomographic Scanning in Sarcoidosis
Lynch, J. P. (2003) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2003-42375 · Cited by 63 · cited 1×
“2), vessels, and in subpleural locations [32, 33].”
Sarcoidosis of the upper respiratory tract (SURT)
James, D. G., Barter, S. J., Jash, D., MacKinnon, D. M., & Carstairs, L. S. (1982) · The Journal of Laryngology & Otology · doi:10.1017/s0022215100093026 · Cited by 63 · cited 1×
“Such combinations include liver and spleen sarcoidosis [172], lupus pernio and nasal sinus involvement (possibly by direct extension) [234, 235], and eye and neurosarcoidosis [235].”
BackgroundSarcoidosis: a long-term follow up study.
Chappell, A. G., Cheung, W. Y., & Hutchings, H. A. (2000) · PubMed · Cited by 63
Clinicopathologic features of ulcerative‐atrophic sarcoidosis
Yoo, S. S., Mimouni, D., Nikolskaia, O. V., Kouba, D. J., Sauder, D. N., & Nousari, C. H. (2004) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.01896.x · Cited by 62 · cited 1×
“Other appearances of specific sarcoidosis lesions include annular lesions [94], plaques [95], psoriaform lesions [88], intradermal nodules “Derrier-Roussy lesions” [96], and ulcers [97, 98].”
BackgroundKataria, Y. P. (1980) · Archives of Internal Medicine · doi:10.1001/archinte.1980.00330130037013 · Cited by 62 · cited 1×
“The most common symptom of splenic sarcoidosis is left upper quadrant abdominal pain from splenomegaly causing stretching of the splenic capsule [176, 177].”
BackgroundSymmetric sarcoid polyneuropathy: Analysis of a sural nerve biopsy
Nemni, R., Galassi, G., Cohen, M., Hays, A. P., Gould, R. V., Singh, N., Bressman, S., & Gamboa, E. T. (1981) · Neurology · doi:10.1212/wnl.31.10.1217 · Cited by 60
Impact of pain in a Dutch sarcoidosis patient population.
Hoitsma, E., Vries, J. D., van Santen‐Hoeufft, M. H. S., Faber, C. G., & Drent, M. (2003) · Research portal (Tilburg University) · Cited by 60
Neurological complications of sarcoidosis.
Chen, R., & McLeod, J. G. (1989) · PubMed · Cited by 59
Oberstein, A., von Zitzewitz, H., Schweden, F., & Müller–Quernheim, J. (1997) · PubMed · Cited by 59
Lehmuskallio, E., Hannuksela, M., & Halme, H. (1977) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1977.tb16829.x · Cited by 58
Multimodality Imaging of Cardiac Sarcoidosis Before and After Steroid Therapy
Tadamura, E., Yamamuro, M., Kubo, S., Kanao, S., Hosokawa, R., Kimura, T., Kita, T., & Togashi, K. (2006) · Circulation · doi:10.1161/circulationaha.105.594200 · Cited by 57
Impaired lung compliance andDL,CObut no restrictive ventilatory defect in sarcoidosis
Boros, P. W., Enright, P., Quanjer, P. H., Borsboom, G. J. J. M., Wesolowski, S. P., & Hyatt, R. E. (2010) · European Respiratory Journal · doi:10.1183/09031936.00166809 · Cited by 53 · cited 1×
“In sarcoidosis patients with stage 1–3 chest radiographs, lung volumes are usually within the normal range [47].”
BackgroundHepatic granulomas: review of 73 patients from one hospital and survey of the literature.
Irani, S. K., & Dobbins, W. O. (1979) · PubMed · Cited by 53
Excessive thoracic computed tomographic scanning in sarcoidosis.
Mañá, J., Teirstein, A. S., Mendelson, D. S., Padilla, M. L., & DePalo, L. (1995) · Thorax · doi:10.1136/thx.50.12.1264 · Cited by 52 · cited 1×
“Despite the fact that HRCT is superior to the chest radiograph in detecting the radiographic abnormalities of pulmonary sarcoidosis, there is insufficient evidence that HRCT has a major clinical role in the management of the disease [38].”
BackgroundClinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients.
Lewis, M.-M., Mortelliti, M. P., Yeager, H., & Tsou, E. (2002) · PubMed · Cited by 51
Hepatic granulomata: problems in interpretation.
Klatskin, G. (1977) · PubMed · Cited by 50
Relationship between perceived stress and sarcoidosis in a Dutch patient population.
Vries, J. D., & Drent, M. (2004) · Research portal (Tilburg University) · Cited by 48
Mortality in sarcoidosis. A changing pattern of the causes of death.
Huang, C. T., Heurich, A. E., Sutton, A. L., & Lyons, H. A. (1981) · PubMed · Cited by 48
Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population.
Cremers, J. P., van Kroonenburgh, M. J. P. G., Mostard, R. L. M., Vöö, S. A., Wijnen, P. A. H. M., Koek, G. H., & Drent, M. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 47
The Prevalence of Sacroiliitis and Spondyloarthritis in Patients with Sarcoidosis
Kobak, Ş., Sever, F., İnce, Ö., & Orman, M. N. (2014) · International Journal of Rheumatology · doi:10.1155/2014/289454 · Cited by 47 · cited 1×
“Sarcoiliitis and spondyloarthritis may be more frequent in sarcoidosis than the general population [224, 225], although it is unknown if this relates to granulomatous inflammation in these locations.”
BackgroundMusculoskeletal and other extrapulmonary disorders in sarcoidosis
Awada, H., Abi-Karam, G., & Fayad, F. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2003.09.005 · Cited by 46 · cited 1×
“Chronic sarcoid arthritis may occasionally cause joint destruction [198].”
BackgroundGalassi, G., Gibertoni, M., Mancini, A., Nemni, R., Volpi, G., Merelli, E., & Vacca, G. (2008) · European Neurology · doi:10.1159/000115728 · Cited by 46 · cited 1×
“Approximately 15 % of neurosarcoidosis patients develop a peripheral neuropathy [152, 154].”
BackgroundPericardial Effusions in Sarcoidosis
Kinney, E. L., Murthy, R., Ascunce, G., Donohoe, R. F., & Zelts, R. (1979) · CHEST Journal · doi:10.1378/chest.76.4.476 · Cited by 44 · cited 1×
“Rare manifestations of cardiac sarcoidosis include pericarditis that is often an initial presentation and is mild and asymptomatic [115, 116].”
BackgroundExcessive Daytime Sleepiness and Obstructive Sleep Apnea in Patients With Sarcoidosis
Patterson, K. C., Huang, F. F.-Y., Oldham, J. M., Bhardwaj, N. J., Hogarth, D. K., & Mokhlesi, B. (2012) · CHEST Journal · doi:10.1378/chest.12-1524 · Cited by 43 · cited 1×
“Fatigue may not be directly related to sarcoidosis but, rather, be associated with corticosteroid use, obstructive sleep apnea, depression, and stress that are common problems in sarcoidosis patients [213–215].”
BackgroundJudson, M. A. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000596 · Cited by 43
Self-citationCT and pathological correlation of pulmonary sarcoidosis
Nishimura, K., Itoh, H., Kitaichi, M., Nagai, S., & Izumi, T. (1995) · Seminars in Ultrasound CT and MRI · doi:10.1016/0887-2171(95)90025-x · Cited by 42 · cited 1×
“2), vessels, and in subpleural locations [32, 33].”
Rare manifestations of sarcoidosis in modern era of new diagnostic tools.
Sharma, S. K., Soneja, M., Sharma, A., Sharma, M. C., & Hari, S. (2012) · PubMed Central · Cited by 42
Clinical aspects of ocular sarcoidosis
Ohara, K., Judson, M. A., & Baughman, R. P. (2005) · European Respiratory Society eBooks · doi:10.1183/1025448x.00032012 · Cited by 42 · cited 4×
“Patients usually present with sudden loss of vision or color vision [73].”
BackgroundInfluentialSelf-citationQuality of Life in Sarcoidosis: Assessment and Management
Vries, J. D., Lower, E. E., & Drent, M. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0030-1262216 · Cited by 41 · cited 2×
“Fatigue may be severe and have a major impact on the health-related quality of life of sarcoidosis patients [213].”
BackgroundSelroos, O. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08243.x · Cited by 41
The Heerfordt-Waldenström Syndrome as an Initial Presentation of Sarcoidosis
Denny, M. C., & Fotino, A. D. (2013) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2013.11929014 · Cited by 38 · cited 1×
“Heerfordt’s syndrome is characterized by the presence of parotid gland enlargement, facial nerve palsy, anterior uveitis, and fever [230–232].”
BackgroundVries, J. D., Drent, M., van Heck, G. L., & Wouters, E. F. �. (1998) · Research portal (Tilburg University) · Cited by 37
Coronary Sarcoidosis Presenting as Acute Coronary Syndrome
Lam, C. S. P., Tolep, K. A., Metke, M. P., Glockner, J., & Cooper, L. T. (2009) · Clinical Cardiology · doi:10.1002/clc.20381 · Cited by 37 · cited 1×
“Coronary artery involvement [117, 118] and large myxoma-like atrial masses [119] are very rare presentations.”
BackgroundObstructive hydrocephalus and progressive psychosis: rare presentations of neurosarcoidosis
Westhout, F. D., & Linskey, M. E. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2007.01.068 · Cited by 37 · cited 1×
“Other relatively rare manifestations of neurosarcoidosis include encephalopathy [138], psychosis [138, 161], hydrocephalus that may be the result of previousmeningeal involvement [161], and seizures [162].”
BackgroundBUTANY, J. W., Bahl, N. E., Morales, K., Thangaroopan, M., Ross, H. J., Rao, V. A., & Leong, S. W. (2006) · Cardiovascular Pathology · doi:10.1016/j.carpath.2006.02.005 · Cited by 36 · cited 1×
“Coronary artery involvement [117, 118] and large myxoma-like atrial masses [119] are very rare presentations.”
BackgroundExtrapulmonary involvement in patients with sarcoidosis in Turkey
Okumuş, G., Müsellim, B., Çetınkaya, E., Türker, H., Uzaslan, E., Yentürk, E., Uzun, O., Sağlam, L., Kumbasar, Ö. Ö., Çelik, G., et al. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01878.x · Cited by 36
A conceptual model of health-related quality of life in sarcoidosis
Victorson, D. E., Cella, D. F., Grund, H., & Judson, M. A. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0438-1 · Cited by 35 · cited 3×
“Other PRO that have been used to measure fatigue in sarcoidosis include the Functional Assessment of Chronic Illness-Therapy Fatigue (FACIT-F) [220], the Fatigue Scale (FS) [211], and the Patient Reported Outcomes Measurement Information Systems (PROMIS) Fatigue Instrument (PFI) [219] that is incorporated as a domain…”
MethodSelf-citationSzabo, B. A., Crişan, D., Tompa, I., & Szabo, I. (2011) · PubMed · Cited by 35
Sarcoidosis Presenting as Spiculated Breast Masses
Gisvold, J. J., Crotty, T. B., & Johnson, R. E. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.3.293 · Cited by 34 · cited 1×
“Sarcoidosis rarely involves the thyroid (that may cause hyper- or hypothyroidism), renal parenchyma [200], muscles [142], tendon sheaths [201], prostate [202], breast [203], and male and female reproductive tracts [202, 204, 205].”
BackgroundPulmonary hypertension complicating sarcoidosis
Nunès, H., Uzunhan, Y., Freynet, O., Humbert, M. J. C., Brillet, P., Kambouchner, M., & Valeyre, D. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.04.003 · Cited by 31 · cited 1×
“The bronchovascular location of the granulomatous lesions would also explain the occasional development of pulmonary hypertension from sarcoidosis [25].”
BackgroundDistinguishing Asthma from Sarcoidosis: An Approach to a Problem that is not Always Solvable
Kalkanis, A., & Judson, M. A. (2012) · Journal of Asthma · doi:10.3109/02770903.2012.747204 · Cited by 30 · cited 3×
“Wheezing is another common symptom of sarcoidosis [15] that may lead the clinician to mis-diagnose sarcoidosis as asthma or another obstructive lung disease [16].”
BackgroundSelf-citationPainless Diplopia Caused by Extraocular Muscle Sarcoid
Patel, A. S. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090190023013 · Cited by 30 · cited 1×
“Extraocular muscles may be affected by cranial nerve involvement [147], although they are more often affected by granulomatous infiltration of the extraocular muscles themselves [81, 148, 149].”
BackgroundJames, D. G., & Sherlock, S. (1994) · PubMed · Cited by 30
Splenectomy in sarcoidosis: indications, complications, and long-term follow-up.
Sharma, O. P., Vucinic, V. M., & James, D. G. (2002) · PubMed · Cited by 30
Lacrimal gland involvement in sarcoidosis
Yanardağ, H., & Pamuk, O. (2003) · Swiss Medical Weekly · doi:10.4414/smw.2003.10125 · Cited by 30
Is There an Anatomic Explanation for Chest Pain in Patients With Pulmonary Sarcoidosis?
Highland, K. B., Retalis, P., Coppage, L., Schabel, S. I., & Judson, M. A. (1997) · Southern Medical Journal · doi:10.1097/00007611-199709000-00010 · Cited by 29 · cited 3×
“The pain is usually pleuritic and substernal or infrascapular in location [18].”
BackgroundInfluentialSelf-citationMarlow, T. J., Krapiva, P., Schabel, S. I., & Judson, M. A. (1999) · CHEST Journal · doi:10.1378/chest.115.1.275 · Cited by 29
Self-citationKalkanis, A., Yucel, R. M., & Judson, M. A. (2013) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 28
Self-citationSarcoidosis: an unusual cause of acute pericarditis
Wyplosz, B., Marijon, É., Dougados, J., & Pouchot, J. (2010) · Acta Cardiologica · doi:10.2143/ac.65.1.2045894 · Cited by 28 · cited 1×
“Rare manifestations of cardiac sarcoidosis include pericarditis that is often an initial presentation and is mild and asymptomatic [115, 116].”
BackgroundPanselinas, E., Halstead, L. A., Schlosser, R. J., & Judson, M. A. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181ebcda5 · Cited by 28 · cited 3×
“SURT may present with hoarseness, sinus pain/pressure, nasal obstruction, epistaxis, nasal crusting, anosmia, or as a mass lesion [89, 179, 180].”
BackgroundSelf-citationMoving on with challenges & new initiatives
Sharma, A. (2012) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.93414 · Cited by 26
Ulcerative Sarcoidosis: Case Report and Review of the Japanese Literature
Ichiki, Y., & Kitajima, Y. (2008) · Acta Dermato Venereologica · doi:10.2340/00015555-0525 · Cited by 26 · cited 1×
“Other appearances of specific sarcoidosis lesions include annular lesions [94], plaques [95], psoriaform lesions [88], intradermal nodules “Derrier-Roussy lesions” [96], and ulcers [97, 98].”
BackgroundMetabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Isiguzo, M., Brunken, R. C., TCHOU, P. J., Xu, M., & Culver, D. A. (2011) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 25
Research works printed but not linked: 3
- Sharma OP (2005) Renal sarcoidosis and hypercalcemia. Eur Resp J Monog 32:220–232
- Jansen TLTA, Geusens PPMM (2005) Sarcoidosis: joint, muscles, and bones. Eur Resp J Monog 32:210–219
- Patel A, Sun JH, Kim I et al (2013) GI tract sarcoidosis: a review. Pract Gastroenterol 37:25–38
Cited by
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Grunewald, J., Grutters, J. C., Arkema, E. V., Saketkoo, L. A., Moller, D. R., & Müller-Quernheim, J. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0096-x · Cited by 479
Mañá, J., Rubio‐Rivas, M., Villalba, N. M., Marcoval, J., Iriarte, A., Molina‐Molina, M., Llatjós, R., García, O., Martínez‐Yélamos, S., Vicens-Zygmunt, V., et al. (2017) · Medicine · doi:10.1097/md.0000000000007595 · Cited by 153
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.
Baughman, R. P., Nagai, S., Balter, M. S., Costabel, U., Drent, M., du Bois, R. M., Grutters, J. C., Judson, M. A., Lambiri, I., Lower, E. E., et al. (2011) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 152
Self-citation
Metadata
- Authors
- Judson, M. A.
- Affiliations
- Albany Medical Center Hospital (US)
- Corresponding author
- Judson, Marc A.
- ORCID
- Judson, Marc A.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2014-10-02
- Volume
- 49
- Issue
- 1
- Pages
- 63-78
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W2065639997
- Cited by
- 281
- References
- 248
- Citations by year
- 2026: 25 · 2025: 22 · 2024: 23 · 2023: 35 · 2022: 18 · 2021: 22 · 2020: 59 · 2019: 21 · 2018: 18 · 2017: 19 · 2016: 12 · 2015: 6 · 2014: 1
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoidosis and Beryllium Toxicity Research
- Health Sciences › Medicine › Hematology › Histiocytic Disorders and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Medical Imaging and Pathology Studies
- Keywords
- sarcoidosis, clinical features, organ involvement, pulmonary sarcoidosis, cardiac sarcoidosis, ocular sarcoidosis, liver involvement, lymphadenopathy, pulmonary fibrosis, sarcoid granulomas, small fiber neuropathy, fatigue syndrome, multisystem involvement
- MeSH terms
- Bone and Bones, Eye, Granuloma, Humans, Hypertension, Pulmonary, Liver, Lung, Lymph Nodes, Myocardium, Pulmonary Fibrosis, Respiratory Function Tests, Sarcoidosis, Severity of Illness Index, Skin, Tomography, X-Ray Computed, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.